Jump to content
Sclero Forums
Sign in to follow this  
CraigR

Primary Thrombosis Prophylaxis in Antiphospholipid (aPL) Antibody-Positive Patients: Where Do We Stand?

Recommended Posts

Primary Thrombosis Prophylaxis in Antiphospholipid (aPL) Antibody-Positive Patients: Where Do We Stand? The protective effect of low-dose aspirin against incident thrombosis in patients with clinically significant aPL profiles is not supported by randomized controlled data. The effectiveness of hydroxychloroquine, statins, or their combination remains to be determined by well-designed randomized controlled trials. Barbhaiya M. (PubMed) Curr Rheumatol Rep. 2010 Nov 23. (Also see: Antiphospholipid Syndrome)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.

 

Craig Roothoff

ISN Assistant News Guide

International Scleroderma Network(ISN)

Share this post


Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Sign in to follow this  

×
×
  • Create New...